Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Products » Medicine World Wide » Hycamtin
Country Product ID Public Price Currency Agent Laboratory Form Dosage Package Size Packaging Route Composition ATC Presentation Pricing Date
Abu Dhabi F82-2421-05564-01 897 AED Novartis Capsule, hard 0.25mg 10 10's Oral Topotecan L01XX17 27/01/2021
Abu Dhabi F76-2421-05565-01 2052.75 AED Novartis Capsule, hard 1mg 10 10's Blister Oral Topotecan L01XX17 27/01/2021
Abu Dhabi F76-2421-05566-01 883.2 AED Novartis Powder for solution for injection 1mg 1 1 Vial Topotecan L01XX17 27/01/2021
Czech Republic 29337 2359.69 CZK Novartis Europharm Limited, Dublin Capsule, hard 0.25mg 10 0,25mg CPS DUR 10 Oral Topotecan L01XX17 28/02/2020
Czech Republic 29338 8788.99 CZK Novartis Europharm Limited, Dublin Capsule, hard 1mg 10 1mg CPS DUR 10 Oral Topotecan L01XX17 28/02/2020
Denmark 090762 1404 DKK Sandoz Capsule, hard 0.25mg 10 10 stk. (blister) Topotecan L01XX17 19/05/2021
Denmark 128182 5595.5 DKK Sandoz Capsule, hard 1mg 10 10 stk. (blister) Topotecan L01XX17 19/05/2021
Denmark 126385 DKK Novartis Capsule, hard 0.25mg 10 10 stk. (blister) Topotecan L01XX17 19/05/2021
Denmark 126374 DKK Sandoz Capsule, hard 1mg 10 10 stk. (blister) Topotecan L01XX17 19/05/2021
Denmark 454850 DKK Sandoz Powder for Concentrate for solution for infusion 4mg 1 1 stk. Topotecan L01XX17 19/05/2021
Finland 165985 EUR Orifarm Powder for concentrate for solution for infusion 4mg 1 1kpl Topotecan L01XX17 Vial 22/04/2021
Finland 165986 EUR Orifarm Powder for concentrate for solution for infusion 4mg 5x4mg 1kpl Topotecan L01XX17 Vial 22/04/2021
Finland 19490 EUR Novartis Powder for solution for injection 1mg 1 1kpl Topotecan L01XX17 Vial 22/04/2021
Finland 19491 EUR Novartis Powder for solution for injection 1mg 5 1kpl Topotecan L01XX17 Vial 22/04/2021
Finland 9141 EUR Novartis Powder for solution for injection 4mg 5 1kpl Topotecan L01XX17 Vial 22/04/2021
Finland 95829 EUR Novartis Capsule, hard 0.25mg 10 10kpl Topotecan L01XX17 Blister 22/04/2021
Finland 95830 EUR Novartis Capsule, hard 1mg 10 10kpl Topotecan L01XX17 Blister 22/04/2021
Finland 192041 EUR Orifarm capsule, hard 1mg 10 10kpl Topotecan L01XX17 Blister 22/04/2021
Finland 154160 EUR Paranova capsule, hard 1mg 10 10kpl Topotecan L01XX17 Blister 22/04/2021
Ireland 88585 534.34 EUR Novartis Capsule, hard 1mg 10 Topotecan L01XX17 08/10/2020
Ireland 88560 130.54 EUR Novartis Capsule, hard 0.25mg 10 Topotecan L01XX17 08/10/2020
Italy 33306061 142.88 EUR Novartis Capsule, hard 0.25mg 10 Oral Topotecan L01XX17 TOPOTECAN 0,25MG 10 UNITA' USO ORALE 17/12/2019
Italy 33306073 571.52 EUR Novartis Capsule, hard 1mg 10 Oral Topotecan L01XX17 TOPOTECAN 1MG 10 UNITA' USO ORALE 17/12/2019
Norway 090762 1443 NOK Novartis Europharm Limited (1) Capsule, hard 0.25mg 10 Blisterpakning Topotecan L01XX17 Blisterpakning/1/10/stk 01/04/2020
Norway 128182 5663.1 NOK Novartis Europharm Limited (1) Capsule, hard 1mg 10 Blisterpakning Topotecan L01XX17 Blisterpakning/1/10/stk 01/04/2020
Norway 454850 3590.2 NOK Novartis Europharm Limited (1) powder for concentrate for Solution pour perfusion 4mg 1 Flacon en verre Topotecan L01XX17 Hetteglass//1/stk 01/04/2020
Sweden 20070709100046 2159.69 SEK Novartis Sverige AB Capsule, hard 0.25mg 10 10 kapslar Topotecan L01XX17 Blister 23/04/2020
Sweden 20070709100053 8500.01 SEK Novartis Sverige AB Capsule, hard 1mg 10 10 kapslar Topotecan L01XX17 Blister 23/04/2020